Antigen-binding molecules comprising unpaired variable domains
AssigneeKymab Limited
InventorsStephen Dowd, Andrew Lindsay Wood, E-Chiang Lee, Hannah Linton Craig, Allan Bradley
Life of this patent
Estimating the term…
Loading patent…
AssigneeKymab Limited
InventorsStephen Dowd, Andrew Lindsay Wood, E-Chiang Lee, Hannah Linton Craig, Allan Bradley
Estimating the term…
Antibodies comprising unpaired variable domains, e.g., heavy chain variable (VH) domains, for binding antigen. Antibody comprising two immunoglobulin (Ig) chains, wherein a first Ig chain comprises a variable domain and a constant domain, and a second Ig chain comprises a constant domain, wherein the second Ig chain lacks a variable domain, leaving the variable domain of the first Ig chain unpaired. The antibody may comprise two Ig heavy chains and two Ig light chains, each heavy chain comprising a VH domain and a constant region comprising a CH1 domain, and each light chain comprising a CL domain, wherein one or both light chains lack a VL domain, thereby leaving one or both VH domains unpaired. Non-human animals (e.g., mice) engineered to produce antibodies having unpaired VH domains, involving deletion of sequence coding for light chain variable (VL) domains. Use of unpaired VH domains to generate antigen-binding molecules.
A non-human animal or non-human animal cell having a genome comprising:
A method of generating a non-human animal comprising B-lymphocytes expressing an antibody comprising an unpaired human VH domain for a binding antigen, comprising:
Dependencies are inferred from the claim text.